Secondary Logo

Journal Logo

AAPA Members can view Full text articles for FREE. Not a Member? Join today!

Institutional members access full text with Ovid®

What is the role of dehydroepiandrosterone in gynecologic practice?

Gajarawala, Shilpa N. DMSc, MPAS, PA-C; Wood, Tiffany A. BSHS; Stanton, Amanda P. MHS, PA-C

Journal of the American Academy of Physician Assistants: December 2019 - Volume 32 - Issue 12 - p 11–12
doi: 10.1097/01.JAA.0000604888.50734.64
Pharmacology Consult
Buy

ABSTRACT In small clinical trials, dehydroepiandrosterone (DHEA) has been found to relieve symptoms associated with postmenopausal conditions and infertility in women. DHEA may provide a cost-effective alternative to typical hormone therapies. Because of a lack of long-term and large-scale studies, only intravaginal DHEA supplementation is approved and recommended for treatment. Further investigation of DHEA supplementation is needed and encouraged to determine its safety and effectiveness.

Shilpa N. Gajarawala is a lead PA in the Department of Medical and Surgical Gynecology at the Mayo Clinic in Jacksonville, Fla., an instructor of obstetrics and gynecology in the Mayo Clinic College of Medicine and Science, and adjunct faculty for the Doctor of Medical Science program at Rocky Mountain University of Health Science in Provo, Utah. Tiffany A. Wood is a clinical assistant in the Department of Medical and Surgical Gynecology at the Mayo Clinic. Amanda P. Stanton practices in the Department of Medical and Surgical Gynecology at Mayo Clinic and is an instructor of obstetrics and gynecology at the Mayo Clinic College of Medicine and Science. The authors have disclosed no potential conflicts of interest, financial or otherwise.

Mary Lou Brubaker, PharmD, PA-C, department editor

Copyright © 2019 American Academy of Physician Assistants
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website